Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Immune‐Checkpoint‐Inhibitor‐Related Bullous Pemphigoid During Avelumab Maintenance Therapy in a Patient With Metastatic Renal Pelvic Carcinoma: A Case Report. Local targets link to admitted publications; unresolved targets remain external evidence.
10.3390/curroncol32040187
10.3390/curroncol32040187 · External reference
10.1016/j.jaad.2020.03.132
10.1016/j.jaad.2020.03.132 · External reference
10.1001/jamadermatol.2022.1624
10.1001/jamadermatol.2022.1624 · External reference
10.3389/fmed.2023.1208418
10.3389/fmed.2023.1208418 · External reference
10.1158/2326-6066.cir-15-0123
10.1158/2326-6066.cir-15-0123 · External reference
10.2340/00015555-3740
10.2340/00015555-3740 · External reference
Guidelines for the Management of Pemphigoid (Including Epidermolysis Bullosa Acquisita) [in Japanese]
2017 · External reference
10.1111/jdv.18220
10.1111/jdv.18220 · External reference
10.1016/j.cpccr.2020.100031
10.1016/j.cpccr.2020.100031 · External reference
10.1200/jco.2015.66.1389
10.1200/jco.2015.66.1389 · External reference
10.1111/j.1365-2133.1995.tb02665.x
10.1111/j.1365-2133.1995.tb02665.x · External reference
10.1001/jamaoncol.2021.4318
10.1001/jamaoncol.2021.4318 · External reference
10.1016/j.jaad.2020.05.045
10.1016/j.jaad.2020.05.045 · External reference
10.1111/bjd.21836
10.1111/bjd.21836 · External reference
10.1200/jco.24.00191
10.1200/jco.24.00191 · External reference
